CR6395A - Quimioterapia de combinacion - Google Patents
Quimioterapia de combinacionInfo
- Publication number
- CR6395A CR6395A CR6395A CR6395A CR6395A CR 6395 A CR6395 A CR 6395A CR 6395 A CR6395 A CR 6395A CR 6395 A CR6395 A CR 6395A CR 6395 A CR6395 A CR 6395A
- Authority
- CR
- Costa Rica
- Prior art keywords
- combination chemotherapy
- combination
- fenil
- paclitaxel
- compound
- Prior art date
Links
- 238000009096 combination chemotherapy Methods 0.000 title 1
- -1 FENIL COMPOUND Chemical class 0.000 abstract 1
- 229940124647 MEK inhibitor Drugs 0.000 abstract 1
- 229930012538 Paclitaxel Natural products 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000002829 mitogen activated protein kinase inhibitor Substances 0.000 abstract 1
- 230000000394 mitotic effect Effects 0.000 abstract 1
- 229960001592 paclitaxel Drugs 0.000 abstract 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
INHIBIDORES MITOTICO TALES COMO EL PACLITAXEL TIENEN ACTIVIDAD ANTITUMORAL MEJORADA UANDO SE USAN EN COMBINACION CON UN INHIBIDOR DE MEK SELECTIVO ESPECIALMENTE UN COMPUESTO FENIL AMINA DE LA FORMULA (I) Y (II).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11329198P | 1998-12-22 | 1998-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR6395A true CR6395A (es) | 2004-03-09 |
Family
ID=27733552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR6395A CR6395A (es) | 1998-12-22 | 2001-06-19 | Quimioterapia de combinacion |
Country Status (2)
| Country | Link |
|---|---|
| CR (1) | CR6395A (es) |
| ZA (1) | ZA200104277B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2370568B1 (en) | 2008-12-10 | 2017-07-19 | Dana-Farber Cancer Institute, Inc. | Mek mutations conferring resistance to mek inhibitors |
| EP3028699B1 (en) | 2010-02-25 | 2018-03-21 | Dana-Farber Cancer Institute, Inc. | Braf mutations conferring resistance to braf inhibitors |
| WO2013169858A1 (en) | 2012-05-08 | 2013-11-14 | The Broad Institute, Inc. | Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy |
-
2001
- 2001-05-24 ZA ZA200104277A patent/ZA200104277B/en unknown
- 2001-06-19 CR CR6395A patent/CR6395A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200104277B (en) | 2002-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9916839A (pt) | Quimioterapia combinada | |
| ECSP941111A (es) | Nuevas sulfonilaminopirimidinas, | |
| MX2008016370A (es) | Buque de perforacion de actividad triple. | |
| ID29076A (id) | Kombinasi senyawa aktif fungisida | |
| NO20052887D0 (no) | Pyridazinonderivater som GSK-3Beta inhibitorer. | |
| MY125333A (en) | Antibacterial compositions containing a solvent, hydrotrope and surfactant. | |
| TW200700393A (en) | Novel cis-2,4,5-triaryl-imidazolines | |
| NO20031006L (no) | Imidazolo-5-yl-2-anilino-pyrimidiner som midler for inhibering av celleproliferasjon | |
| WO2004009616A3 (en) | Ghrelin analogs | |
| BR9906070A (pt) | Benzamidas substituìdas | |
| ES2163867T3 (es) | Composicion para el control del polvo. | |
| PT1718322E (pt) | Composições sinérgicas com fk-228 | |
| MY123585A (en) | Tri-aryl-substituted-ethane pde4 inhibitors. | |
| ES2151249T3 (es) | Hidroxiamidino-derivados utiles como inhibidores de oxido nitrico sintasa. | |
| ATE476419T1 (de) | Isochinolinon-kaliumkanalinhibitoren | |
| ITMI20031714A1 (it) | Formazioni ad azione antitumorale. | |
| EP0995757A3 (en) | Bivalent inhibitors of the proteasome | |
| AR043327A1 (es) | Uso de inhibidores de quinurenina 3- hidroxilasa para el tratamiento de la diabetes | |
| PL376130A1 (en) | Controlled releases system containing temozolomide | |
| MX9304152A (es) | Inhibidores de enzimas. | |
| AR026901A1 (es) | Peptidos con n-alquilacion que tienen actividad antiangiogenica | |
| WO2002048143A3 (en) | Antimicrobial 2-pyridones, their compositions and uses | |
| MXPA04003851A (es) | Antipruriticos. | |
| NO20052478D0 (no) | Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse. | |
| DE60332822D1 (de) | Cholinesterase-inhibitor sowie dessen isolierung aus dem pilz sporotrichum species |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |